Gen Digital Inc
(NASDAQ:GEN)

Gen Digital Inc. is a multinational software company co-headquartered in Tempe, Arizona and Prague, Czech Republic. The company provides cybersecurity software and services. Gen is a Fortune 500 company and a member of the S&P 500 stock-market index.

Website: https://www.gendigital.com/

Founded: 1982

Full Time Employees: 55,000

Sector: Healthcare

Industry: Medical Care Facilities

Healthcare Technology

Share this website to your friends

• Market Cap:

• Exchange:

• Shs Outstanding:

• Employees:

• Beta:

• Return on Equity (ROE) ttm:

• Return on Assets (ROA) ttm:

• EPS ttm:

• Book value per Share:

• Cash per Share:

• Current ast per Share:

• P/E ttm:

• P/E forward:

• P/E ttm high:

• P/E ttm low:

• P/S ttm:

• P/B ttm:

• P/FCF ttm:

• PEG ratio:

• Cash Ratio ttm:

• Quick Ratio ttm:

• Current Ratio ttm:

• Gross Mgn ttm:

• EBITDA Mgn ttm:

• Operating Mgn ttm:

• Net Income Mgn ttm:

• Trailing Div yield:

• Forward Div yield:

• Payout Ratio ttm:

• Ex-Dividend date:

• Target Price High:

• Target Price Low:

• Target Price Mean:

• Number of Analysts:

• Debt Ratio ttm:

• Debt to Equity ttm:

• Total Net Debt:

At a glance:

Bull Thesis:

Bear Thesis:

Main Competitors:

Moat:

Income Statements:

Quarterly

Annual

Unit: USD	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30

net revenues	919,061,000	938,653,000	956,259,000	1,092,250,000	1,135,437,000	1,123,705,000	1,145,052,000	1,161,640,000	1,185,947,000	1,217,271,000	1,272,360,000	1,301,072,000	1,327,880,000	1,315,452,000	1,341,276,000	1,389,132,000	1,402,860,000	1,418,994,000	1,438,358,000	1,472,218,000	1,440,721,000	1,416,027,000	1,419,475,000	1,343,001,000
salaries, wages and benefits	523,714,000	535,009,000	616,944,000	580,533,000	595,948,000	620,493,000	626,159,000	642,410,000	664,780,000	680,604,000	705,754,000	735,770,000	733,568,000	739,404,000	739,402,000	824,494,000	834,889,000	834,414,000	832,693,000	867,717,000	844,746,000	833,415,000	820,926,000	819,938,000
other operating expenses	303,152,000	309,664,000	317,274,000	340,481,000	360,340,000	339,441,000	332,528,000	342,538,000	354,101,000	371,064,000	370,555,000	384,160,000	394,255,000	375,587,000	372,295,000	342,257,000	351,553,000	350,828,000	350,161,000	361,097,000	365,268,000	332,918,000	348,236,000	348,285,000
general and administrative costs	50,499,000	45,172,000	39,769,000	39,617,000	37,447,000	35,930,000	35,562,000	35,532,000	34,778,000	35,482,000	39,046,000	39,875,000	42,988,000	40,732,000	41,187,000	45,122,000	46,063,000	46,545,000	45,026,000	48,427,000	44,763,000	46,110,000	44,983,000
lease expense	85,677,000	86,247,000	96,395,000	98,020,000	98,398,000	100,018,000	94,586,000	94,061,000	32,311,000	32,366,000	32,111,000	33,071,000	34,521,000	38,670,000	38,234,000	36,100,000	36,448,000	35,512,000	36,968,000	37,316,000	37,243,000	37,655,000	38,959,000	36,419,000
depreciation and amortization expense	23,656,000	24,373,000	33,816,000	25,988,000	21,764,000	34,932,000	28,268,000	38,195,000	52,860,000	53,038,000	63,495,000	51,503,000	71,800,000	59,390,000	60,227,000	64,369,000	63,637,000	61,104,000	67,953,000	61,765,000	61,574,000	62,505,000	53,605,000	59,933,000
interest expense	33,374,000	33,918,000	31,907,000	36,240,000	38,802,000	37,099,000	52,975,000	51,516,000	115,051,000	115,695,000	117,955,000	115,037,000	125,909,000	124,431,000	124,288,000	124,754,000	127,691,000	131,812,000	133,860,000	135,181,000	131,573,000	128,538,000	126,385,000	121,313,000	-7,984,000	-8,009,000	-7,945,000	-8,039,000	-8,105,000	-8,744,000	-8,734,000	-8,675,000	-8,884,000	-8,790,000	-10,521,000	-9,565,000	-9,675,000	-9,711,000	-9,662,000	-9,946,000	-10,486,000	-10,086,000	-9,164,000	-7,284,000	-8,265,000	-8,417,000	-8,241,000	-8,090,000	-9,239,000	-9,207,000	-9,162,000	-9,653,000	-10,177,000	-9,914,000	-11,926,000
loss on early extinguishment of debt	2,418,000	1,101,000	1,421,000	4,039,000	-2,558,000	2,460,000	-24,000		2,446,250		-501,000	10,286,000	-8,867,000		2,301,000		460,000	15,363,000	468,000					3,234,000
investment income	-915,000	-957,000	-961,000	-1,156,000	-1,218,000	-2,071,000	-2,143,000	-1,864,000	-1,976,000	-2,178,000	-1,631,000	-1,047,000	-1,231,000	-1,596,000	-1,392,000	-1,109,000	-945,000	-934,000	-658,000	-481,000	-477,000	-353,000	-431,000
other income	-19,833,000	-53,507,000	-44,100,000	-84,832,000	-1,364,000	-131,811,000	-23,413,000																		-33,000	-26,000	7,000	52,000	299,000	-49,000	-32,000	-30,000	-52,000	-57,000	106,000	-29,000	-22,000	-123,000	-30,000	-324,000	1,744,000	9,000	583,000	-4,000	151,000	59,000		-60,000	48,000	-110,000	87,000
transaction costs	7,583,000	15,561,000	5,543,000	5,591,000	3,337,000	12,941,000	8,823,000	1,261,000	5,386,000	11,361,000	3,112,000	12,095,000	6,463,000	1,056,000	3,781,000	3,025,000	-1,876,000	3,057,000	4,993,000	1,754,000	4,358,000	3,306,000	2,642,000	86,069,000
long-lived asset impairments	19,800,000	72,400,000	77,100,000	9,700,000		16,037,000	900,000		16,989,000	32,390,000	27,257,000	28,360,000	28,011,000	163,364,000
federal stimulus - covid-19 other income	-54,178,250	-31,212,000	-185,500,000
equity in net income of unconsolidated affiliates	-1,358,000	-3,362,000	-3,576,000	127,000									48,000	-69,000	-88,000	-134,000	-538,250	-893,000	-497,000	-763,000			-360,000
income before income tax expense	-19,352,000	-95,754,000		37,902,000
income tax expense	-2,550,000	176,000		-779,000				51,000	-439,750	-1,220,000	-886,000	347,000	-16,110,000	1,596,000	2,803,000	1,284,000				3,064,000
net income	-16,802,000	-95,930,000	-29,316,000	38,681,000	-17,359,000	58,898,000	-8,983,000	-25,082,000	-108,986,000	-91,901,000	-62,857,000	-108,673,000	-155,017,000	-615,024,000	-105,550,000	-83,613,000	41,314,000	-52,379,000	-35,958,000	-71,028,000	-312,640,000	-60,942,000	-34,936,000		-64,000	643,000	-2,780,000	1,295,000	-3,002,000	-12,075,000	1,523,000	3,070,000	5,695,000	6,068,000	3,497,000	6,337,000	6,930,000	-232,611,000	10,571,000	11,844,000	10,841,000	-25,307,000	4,545,000	8,881,000	-161,316,000	9,052,000	9,079,000	10,867,000	10,265,000	9,576,000	8,924,000	8,444,000	7,184,000	6,864,000	-1,553,000
yoy	-3.21%	-262.87%	226.35%	-254.22%	-84.07%	-164.09%	-85.71%	-76.92%	-29.69%	-85.06%	-40.45%	29.97%	-475.22%	1074.18%	193.54%	17.72%	-113.21%	-14.05%	2.93%		488400.00%	-9577.76%	1156.69%		-97.87%	-105.33%	-282.53%	-57.82%	-152.71%	-298.99%	-56.45%	-51.55%	-17.82%	-102.61%	-66.92%	-46.50%	-36.08%	819.16%	132.59%	33.36%	-106.72%	-379.57%	-49.94%	-18.28%	-1671.51%	-5.47%	1.74%	28.69%	42.89%	39.51%	-674.63%
qoq	-82.49%	227.23%	-175.79%	-322.83%	-129.47%	-755.66%	-64.19%	-76.99%	18.59%	46.21%	-42.16%	-29.90%	-74.79%	482.68%	26.24%	-302.38%	-178.88%	45.67%	-49.37%	-77.28%	413.01%	74.44%			-109.95%	-123.13%	-314.67%	-143.14%	-75.14%	-892.84%	-50.39%	-46.09%	-6.15%	73.52%	-44.82%	-8.56%	-102.98%	-2300.46%	-10.75%	9.25%	-142.84%	-656.81%	-48.82%	-105.51%	-1882.10%	-0.30%	-16.45%	5.86%	7.20%	7.31%	5.68%	17.54%	4.66%	-541.98%
net income margin %	-Infinity%	-Infinity%	-Infinity%	Infinity%	-Infinity%	Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	NaN%	-Infinity%	Infinity%	-Infinity%	Infinity%	-Infinity%	-Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	-Infinity%	Infinity%	5.32%	4.91%	-12.10%	2.26%	4.69%	-85.35%	4.81%	4.69%	5.74%	5.41%	5.25%	4.95%	4.67%	4.05%	4.25%	-1.03%
less net loss attributable to noncontrolling interests	9,129,000	33,137,000	7,311,000	-5,173,000	5,963,000	-12,801,000	4,164,000	9,819,000	24,288,250	33,773,000	23,245,000	40,135,000	65,776,000	241,200,000	40,394,000	32,852,000	-18,857,000	31,921,000		27,989,000				5,684,000
net income attributable to genesis healthcare, inc.	-7,673,000	-62,793,000	-22,005,000	33,508,000	-11,396,000	46,097,000													-22,973,000		-40,176,000	-28,952,000	-19,186,000
earnings per common share:
basic:
weighted-average shares outstanding for basic net income per share	111,851	113,145	111,232	109,721	107,286	109,123
basic net income per common share attributable to genesis healthcare, inc.	-0.07	-0.55	-0.2	0.31	-0.1	0.42
diluted:
weighted-average shares outstanding for diluted net income per share	111,851	113,145	111,232	167,414	165,314	166,002
diluted net income per common share attributable to genesis healthcare, inc.	-0.07	-0.55	-0.2	0.24	-0.11	0.4
income before income tax benefit			-29,773,000		6,038,250	58,329,000													-32,933,000		-59,837,500	-77,707,000	-37,633,000
income tax benefit			-457,000		-170,000	-569,000	-162,000										-4,934,500	-25,888,000	3,086,000		-6,698,250	-16,726,000	-4,419,000
goodwill and identifiable intangible asset impairments									1,477,000	929,000	1,132,000			360,046,000
equity in net loss of unconsolidated affiliates					-44,500	-93,000	-24,000	-61,000	26,500	-152,000	38,000	220,000
loss before income tax benefit							-9,145,000										-44,775,500	-78,243,000
net loss attributable to genesis healthcare, inc.							-4,819,000	-15,263,000	-41,569,500	-58,128,000	-39,612,000	-68,538,000	-89,241,000	-373,824,000	-65,156,000	-50,761,000	22,457,000	-20,458,000		-43,039,000				-112,566,000
loss per common share:
basic and diluted:
weighted-average shares outstanding for loss from continuing operations per share							106,846	103,715		102,489	100,596	98,252	94,217	94,940	93,273	91,880	89,873
other loss								-16,917,000	-10,590,000	-20,207,000	-22,220,000	68,000	-7,129,000	2,379,000	4,190,000	9,034,000	-12,021,000	-5,173,000		12,000	6,122,000	38,000	50,000
loss before income tax expense								-25,031,000	-66,297,500	-93,121,000	-63,743,000	-108,326,000	-171,165,000	-613,426,000	-102,700,000	-82,308,000				-67,926,000
customer receivership and other related charges
loss from continuing operations									-65,857,750	-91,901,000	-62,857,000	-108,673,000	-155,055,000	-615,022,000	-105,503,000	-83,592,000	41,286,000	-52,355,000		-70,990,000
loss from discontinued operations, net of taxes													-17,500			-21,000
net loss per common share:
loss from continuing operations attributable to genesis healthcare, inc.									-0.415	-0.57	-0.39	-0.7	-0.91	-3.94	-0.7	-0.55	0.25	-0.23		-0.48				-1.5
provision for losses on accounts receivable													23,709,000	25,187,000	23,985,000	23,528,000	26,039,000	25,602,000		26,493,000
customer receivership													8,966,000	297,000	35,566,000
skilled healthcare and other loss contingency expense																			13,566,000	1,626,000
income from discontinued operations, net of taxes															-47,000			-24,000	61,000	-38,000			-1,722,000	112,000
weighted-average shares outstanding for basic and diluted loss from continuing operations per share																		90,226		89,198	85,755
basic and diluted net loss per common share:
benefit from losses on accounts receivable																			29,681,000		17,213,750	23,346,000	22,113,000
other (income) loss																			-42,923,000
income from continuing operations																			-36,019,000		-53,139,250	-60,981,000	-33,214,000		-64,000	643,000	-2,780,000	1,295,000													10,841,000	-25,307,000	4,545,000	8,881,000	-161,316,000	9,295,000
less net income attributable to noncontrolling interests																			12,985,000
weighted-average shares outstanding for basic and diluted income from continuing operations per share																			89,421			89,213	89,211	75,234
basic and diluted net income per common share:
income from continuing operations attributable to genesis healthcare, inc.																			-0.26		-0.47	-0.32	-0.2
(gain) loss on early extinguishment of debt																					32,500	-3,104,000
skilled healthcare loss contingency expense																						30,000,000
equity in net (income) loss of unconsolidated affiliates																					-288,250	-640,000
gain from discontinued operations, net of taxes																					-392,750	39,000
less net income (income) attributable to noncontrolling interests																					13,356,000	31,990,000	15,750,000
income from discontinued operations																					-0.005		-0.02
revenue:
net patient service revenue																									209,559,000	207,811,000	206,172,000	206,513,000	196,473,000	211,658,000	212,905,000	218,114,000	218,443,000	215,854,000	216,607,000	218,659,000	213,674,000	216,409,000	214,801,000
leased facility revenue																									800,000	807,000	807,000	787,000	787,000	787,000	787,000	761,000	769,000	769,000	768,000	754,000	747,000	746,000	746,000
expenses:
cost of services																									179,337,000	176,689,000	178,529,000	180,309,000	170,730,000	184,627,000	186,376,000	190,137,000	185,385,000	182,243,000	180,215,000	183,131,000	177,021,000	173,548,000	171,249,000	175,461,000	175,224,000	168,579,000	162,007,000	151,705,000	152,324,000	152,457,000	154,257,000	148,804,000	148,333,000	145,749,000	142,252,000	142,144,000	131,931,000	120,826,000	113,494,000
rent cost of revenue																									5,158,000	5,146,000	4,922,000	4,774,000	4,238,000	4,950,000	4,828,000	4,812,000	4,773,000	4,639,000	4,539,000	4,556,000	4,869,000	4,413,000	4,547,000	4,570,000	4,829,000	4,796,000	4,832,000	4,581,000	4,569,000	4,509,000	4,568,000	4,539,000	4,515,000	4,771,000	4,478,000	4,465,000
general and administrative																									13,838,000	12,780,000	7,287,000	6,084,000	6,837,000	6,490,000	6,837,000	6,455,000	5,701,000	6,021,000	6,427,000	6,100,000	6,177,000	5,423,000	7,237,000	6,893,000	7,037,000	6,016,000	6,112,000	6,351,000	5,684,000	6,343,000	6,823,000	6,240,000	6,766,000	5,992,000	5,557,000	6,222,000	14,008,000	12,008,000	10,403,000
change in fair value of contingent consideration																									-476,000	7,000	-121,000	14,000	-1,620,000	79,000	-2,244,000
depreciation and amortization																									6,082,000	6,120,000	6,034,000	6,085,000	5,375,000	6,130,000	6,130,000	6,219,000	6,276,000	6,258,000	6,591,000	6,275,000	6,193,000	6,459,000	6,432,000	6,145,000	6,806,000	6,305,000	5,992,000	5,944,000	5,950,000	6,014,000	5,867,000	5,477,000	5,444,000	5,301,000	5,073,000	5,160,000	5,068,000	4,420,000	4,239,000
governmental investigation expense																											6,000,000
impairment of long-lived assets																											82,000			19,000,000								270,478,000
loss on disposal of asset																									18,250	68,000	5,000
other (expenses) income:
interest income																									219,000	173,000	302,000	43,000	48,000	63,000	112,000	112,000	110,000	125,000	132,000	145,000	161,000	170,000	208,000	175,000	263,000	260,000	196,000	228,000	250,000	285,000	420,000	191,000	174,000	169,000	123,000	214,000	289,000	384,000
equity in earnings of joint venture																									221,000	568,000	92,000	546,000	480,000	508,000	472,000	489,000	526,000	461,000	490,000	471,000	372,000	472,000	557,000	554,000	345,000	746,000	678,000	797,000	521,000	746,000	751,000	733,000	754,000	624,000	718,000	391,000	329,000	381,000	353,000
debt modification/retirement costs																										-21,000	-822,000		-1,308,000	-432,000	-1,088,000
total other (expenses) income																									-5,769,500	-7,315,000	-8,366,000	-7,398,000	-8,586,000	-8,654,000	-9,270,000	-8,104,000	-8,300,000	-8,429,000	-13,751,000
income from continuing operations before benefit from income taxes																									-249,000	493,000															18,719,000	-39,073,000	7,311,000	14,475,000	-157,474,000	11,715,000
benefit from income taxes																									-38,250	-150,000							2,339,000	2,965,000	2,355,000	4,036,000	4,067,000	-15,259,000	6,584,000	8,124,000			2,766,000	5,594,000	3,842,000	2,420,000	5,736,000	6,298,000	6,195,000	2,561,000	5,830,000	5,466,000	5,330,000	4,801,000
loss from discontinued operations, net of tax
earnings per share, basic:
earnings per common share from continuing operations																										0.02	-0.07	0.03													0.29	-0.68	0.12	0.24	-4.37	0.25
loss per share from discontinued operations
earnings per share																									-0.005	0.02	-0.07	0.03											0.28	0.32	0.29	-0.68	0.12	0.24	-4.37	0.24
earnings per share, diluted:
weighted-average common shares outstanding, basic																									38,125	38,207	38,098	37,972	37,533	37,499	37,646	37,557	37,389	37,431	37,400	37,285	37,145	37,164	37,154	37,079	36,988	36,997	36,983	36,962	36,914	36,927	36,904	36,881	36,573	36,578	36,558	36,551	27,062	36,236	23,436,598
weighted-average common shares outstanding, diluted																									38,125	38,463	38,098	38,202	37,533	37,499	38,186	38,034	37,589	37,503	37,497	37,407	37,145	37,164	37,354	37,326	36,988	36,997	37,084	37,037	36,914	36,950	36,928	36,911	36,894	36,909	36,871	36,881	27,715	36,917	23,436,598
income from continuing operations before provision for income taxes																											-4,125,000	2,636,000
provision for income taxes																											-1,345,000	1,341,000	1,455,000	-5,410,000	972,000	78,000
income before provision for income taxes																													-2,960,500	-17,485,000	2,495,000	3,148,000
net income per share																													-0.05	-0.32	0.04	0.08
litigation settlement costs,																																						-4,488,000
debt retirement costs																																		-168,000	-3,958,000								-7,010,000
income before benefit from income taxes																																	6,314,500	9,033,000	5,852,000	10,373,000	-52,686,750	-247,870,000	17,155,000	19,968,000							14,815,000	17,165,000	16,460,000	12,137,000	14,754,000	13,910,000	4,396,750	11,665,000
income per share, basic																																	0.16	0.16	0.09
income per share, diluted																																	0.15	0.16	0.09
total other income (expenses)																																				-8,978,000	-6,915,000	-9,192,000	-8,927,000									-7,226,000	-8,263,000	-8,524,000	-8,234,000	-8,826,000	-9,473,000	-9,314,000	-22,537,000
income per share																																				0.17
loss per share, basic
loss per share																																					0.19	-6.26
loss per share, diluted
revenue																																								222,578,000	220,749,000	209,199,000	200,971,000	189,319,000	188,996,000	188,365,000	193,400,000	189,451,000	189,781,000	182,474,000	180,348,000	180,727,000	177,392,000	161,468,000	151,091,000
yoy																																								17.57%	16.80%	11.06%	3.91%	-0.07%	-0.41%	3.23%	7.24%	4.83%	6.98%	13.01%	19.36%
qoq																																								0.83%	5.52%	4.09%	6.15%	0.17%	0.33%	-2.60%	2.08%	-0.17%	4.00%	1.18%	-0.21%	1.88%	9.86%	6.87%
total other incomes																																								-9,541,000	-7,513,000	-9,071,000	-14,717,000	-6,263,000	-5,405,750	-7,327,000	-7,070,000
litigation settlement costs																																										53,505,000
benefit for income taxes																																									-1,351,500	-13,766,000													-556,000
income from discontinued operations, net of tax																																														-243,000
loss per common share from discontinued operations																																														-0.01
earnings per share data:
earnings per common share, basic																																															0.25	0.29
earnings per common share, diluted																																															0.25	0.29
premium on redemption of debt and write-off of related deferred financing costs																																																							-11,648,000
change in fair value of interest rate hedge																																																						-6,000
accretion on preferred stock																																																							-2,583,000
net income attributable to common stockholders																																																	10,265,000	9,576,000	8,924,000	8,444,000	7,184,000	6,864,000	-4,136,000
net income per common share, basic																																																	0.185	0.26	0.24	0.23	0.25	0.19	-0.18
net income per common share, diluted																																																	0.183	0.26	0.24	0.23	0.24	0.19	-0.18
other																																																				222,000	86,000	-159,000
rent cost of sales																																																					2,114,000	3,235,000	2,527,000
interest income and other																																																							684,000
income before benefit for income taxes																																																							-2,109,000

Balance Sheets:

Quarterly

Annual

Unit: USD	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30

assets:
current assets:
cash and cash equivalents	212,071,000	200,995,000	251,651,000	23,502,000	12,097,000	34,837,000	11,857,000	14,464,000	20,865,000	23,170,000	78,932,000	57,705,000	54,525,000	50,591,000	64,745,000	51,793,000	51,408,000	53,840,000	46,678,000	52,204,000	61,543,000	59,671,000	82,963,000		3,629,000	10,536,000	7,960,000	4,205,000	4,177,000	2,595,000	2,019,000	5,149,000	2,003,000	3,199,000	5,572,000	9,881,000	16,017,000	16,442,000	15,015,000	940,000	4,192,000	3,200,000	157,000	2,107,000	3,528,000	3,235,000	12,174,000	7,453,000	2,047,000	4,327,000	3,713,000	3,992,000	5,012,000	325,000	2,333,000
restricted cash and equivalents	49,998,000	45,437,000	62,664,000	47,285,000	63,101,000	42,807,000	32,600,000	31,921,000	73,762,000	48,675,000	6,949,000	6,451,000
restricted investments in marketable securities	39,526,000	39,682,000	39,682,000	31,855,000	31,855,000	35,950,000	35,950,000	35,631,000	35,631,000	36,780,000	29,831,000
accounts receivable	426,927,000	456,023,000	459,354,000	553,520,000	567,636,000	545,259,000	558,907,000	602,374,000	622,717,000	642,993,000	687,970,000	724,960,000	724,138,000	774,052,000	754,384,000	808,669,000	832,109,000	826,221,000	819,919,000	821,199,000	789,387,000	759,305,000	753,563,000	763,006,000
prepaid expenses	93,476,000	118,051,000	69,617,000	73,774,000	108,908,000	81,661,000	67,038,000	73,971,000	82,747,000	76,720,000	65,368,000	71,781,000	74,368,000	83,878,000	68,139,000	63,594,000	64,218,000	63,873,000	80,743,000	89,447,000	58,622,000	83,674,000	48,961,000	49,112,000	5,689,000	5,019,000	6,009,000	10,609,000	8,961,000	8,983,000	3,355,000	7,335,000	7,569,000	8,220,000	5,255,000	7,445,000	6,943,000	8,372,000	5,712,000	9,137,000	9,618,000	6,107,000	5,888,000	9,003,000	8,159,000	11,952,000	4,820,000	7,380,000	9,226,000	11,203,000	4,113,000	5,012,000	5,708,000	5,722,000	2,858,000
other current assets	47,132,000	37,225,000	41,723,000	43,845,000	44,079,000	39,014,000	33,702,000	42,115,000	36,528,000	53,173,000	50,239,000	52,539,000	49,748,000	46,306,000	55,097,000	58,879,000	63,641,000	63,480,000	56,979,000	64,204,000	49,024,000	47,404,000	40,573,000	38,453,000	10,303,000	12,858,000	11,115,000	11,610,000	12,188,000	10,580,000	11,169,000	10,594,000	10,312,000	8,493,000	10,127,000	8,732,000	9,203,000	9,866,000	10,744,000	17,522,000	15,819,000	20,747,000	11,791,000	7,468,000	8,303,000	6,828,000	7,115,000	6,916,000	7,483,000	5,625,000	13,830,000	11,450,000	11,697,000	14,365,000	14,527,000
assets held for sale					1,171,000	4,740,000	6,574,000	8,539,000	3,375,000	9,533,000	9,278,000	8,821,000				4,064,000	4,056,000
total current assets	869,130,000	897,413,000	924,691,000	773,781,000	828,847,000	784,268,000	746,628,000	809,015,000	875,625,000	891,044,000	928,567,000	952,934,000	939,907,000	998,792,000	986,330,000	1,030,549,000	1,058,987,000	1,048,666,000	1,056,896,000	1,079,971,000	1,011,493,000	1,004,160,000	978,828,000	1,000,956,000	161,383,000	157,638,000	147,372,000	145,567,000	142,417,000	140,322,000	150,253,000	147,931,000	138,825,000	141,157,000	142,390,000	147,500,000	143,331,000	149,287,000	148,710,000	147,655,000	148,825,000	144,520,000	130,773,000	131,439,000	131,603,000	141,101,000	146,451,000	155,917,000	148,675,000	148,512,000	146,119,000	159,750,000	150,304,000	135,829,000	123,474,000
property and equipment	984,712,000	1,018,939,000	831,333,000	853,793,000	962,105,000	957,218,000	673,911,000	679,749,000	2,887,554,000	2,919,584,000	3,017,243,000	3,212,156,000	3,413,599,000	3,470,946,000	3,670,151,000	3,709,242,000	3,765,393,000	3,944,620,000	3,957,245,000	3,981,879,000	4,085,247,000	3,965,527,000	3,995,294,000	3,947,941,000																											318,971,000	299,322,000	294,281,000	289,063,000	267,456,000
finance lease right-of-use assets, net of accumulated amortization of 16,328 and 23,401 at december 31, 2020 and december 31, 2019, respectively	27,848,000
operating lease right-of-use assets	1,715,532,000	1,817,603,000	2,134,233,000	2,353,477,000	2,399,505,000	2,416,914,000	2,200,252,000	2,235,128,000
other long-term assets	116,371,000	120,098,000	108,563,000	109,400,000	85,725,000	120,738,000	119,479,000	114,897,000	125,595,000	107,550,000	105,206,000	106,338,000	109,060,000	122,144,000	132,659,000	136,764,000	137,602,000	134,935,000	129,874,000	125,666,000	162,390,000	161,520,000	172,144,000	163,326,000
deferred income taxes	2,278,000	1,946,000	4,702,000	4,391,000	3,772,000	5,617,000	5,482,000	5,775,000	5,867,000	5,151,000	5,032,000	3,330,000	3,580,000	5,754,000	6,358,000	6,274,000	6,107,000	5,721,000	16,559,000	6,485,000	7,144,000	2,657,000	2,657,000	2,443,000	17,659,000	14,627,000	11,845,000	9,736,000	9,876,000	11,055,000	11,430,000	12,348,000	11,696,000	12,093,000	12,644,000	11,429,000	11,404,000	12,512,000	13,006,000	12,152,000	20,419,000	19,695,000	14,567,000	14,673,000	15,003,000	17,558,000	21,218,000	14,745,000	14,708,000			13,088,000	14,968,000	13,979,000	14,060,000
identifiable intangible assets, net of accumulated amortization of 81,387 and 76,243 at december 31, 2020 and december 31, 2019, respectively	82,270,000
goodwill	85,642,000	85,642,000	85,642,000	85,642,000	85,642,000	85,642,000	85,642,000	85,642,000	85,642,000	85,642,000	85,642,000	85,642,000	85,642,000	85,642,000	439,212,000	439,912,000	440,712,000	444,113,000	444,508,000	470,735,000	470,019,000	444,446,000	431,515,000	423,387,000	68,833,000	68,833,000	68,983,000	69,065,000	69,065,000	69,065,000	85,609,000	85,609,000	85,609,000	85,609,000	85,609,000	84,299,000	84,299,000	72,847,000	332,724,000	332,724,000	332,724,000	336,404,000	336,404,000	279,362,000	279,362,000	449,962,000	449,962,000	449,962,000	449,962,000	450,189,000	451,711,000	450,040,000	449,710,000	448,047,000	418,857,000
total assets	4,062,246,000	4,214,625,000	4,366,334,000	4,488,981,000	4,662,140,000	4,674,147,000	4,642,580,000	4,779,923,000	4,263,623,000	4,391,374,000	4,544,817,000	4,771,539,000	4,787,865,000	4,926,928,000	5,514,788,000	5,688,509,000	5,779,201,000	5,886,587,000	5,933,018,000	6,005,750,000	6,091,470,000	6,121,361,000	6,103,378,000	6,031,356,000	650,956,000	649,897,000	643,961,000	644,814,000	643,416,000	661,912,000	684,974,000	684,516,000	682,636,000	684,586,000	689,133,000	696,482,000	695,000,000	693,888,000	939,015,000	941,111,000	937,730,000	935,336,000	926,459,000	859,020,000	856,242,000	1,030,786,000	1,034,294,000	1,030,224,000	1,013,842,000	1,007,302,000	992,261,000	986,473,000	970,107,000	952,056,000	884,792,000
liabilities and stockholders' deficit:
current liabilities:
current portion of long-term debt	905,788,000	10,693,000	19,116,000																						12,456,000	13,173,000	10,198,000	10,172,000	7,630,000	17,446,000	12,306,000	13,460,000	13,338,000	14,493,000	11,925,000	5,273,000	4,414,000	6,287,000	6,588,000
current portion of finance lease obligations	2,949,000	2,958,000	2,947,000
current portion of operating lease obligations	2,071,841,000	126,974,000	135,853,000
accounts payable	211,357,000	190,264,000	210,870,000	195,356,000	238,384,000	254,443,000	230,474,000	241,065,000	234,786,000	239,514,000	251,644,000	259,360,000	285,637,000	241,145,000	233,089,000	254,891,000	258,616,000	223,961,000	211,127,000	224,850,000	233,801,000	201,800,000	205,586,000	218,565,000
accrued expenses	335,837,000	324,354,000	364,973,000	226,692,000	226,092,000	219,120,000	218,105,000	220,596,000	227,813,000	215,384,000	201,790,000	213,705,000	233,856,000	220,376,000	192,137,000	166,465,000	215,457,000	205,096,000	207,155,000	194,791,000	197,741,000	193,668,000	155,370,000	155,484,000
accrued compensation	162,870,000	145,439,000	147,281,000	154,058,000	153,698,000	153,488,000	155,639,000	164,299,000	172,726,000	165,309,000	156,773,000	168,834,000	167,368,000	163,727,000	161,396,000	189,477,000	181,841,000	185,916,000	225,382,000	246,828,000	185,054,000	222,689,000	226,745,000	255,881,000
self-insurance reserves	153,669,000	149,793,000	149,793,000	149,655,000	146,476,000	137,111,000	137,111,000	149,545,000	149,545,000	180,459,000	180,459,000	180,982,000	180,982,000	168,933,000	168,933,000	172,565,000	172,565,000	162,149,000	161,382,000	166,761,000	166,761,000	146,884,000	146,884,000	144,897,000
current portion of liabilities held for sale	403,000	400,000	394,000	728,000	368,000	1,020,000	1,257,000	1,763,000	639,000	2,123,000	2,110,000	2,097,000				997,000	988,000
total current liabilities	3,844,714,000	950,875,000	1,031,227,000	977,694,000	1,071,170,000	1,027,239,000	964,059,000	977,194,000	912,212,000	922,977,000	904,256,000	859,401,000	899,194,000	5,502,595,000	784,566,000	824,043,000	857,560,000	811,298,000	816,654,000	844,420,000	798,665,000	780,363,000	750,362,000	791,675,000	115,292,000	120,113,000	109,451,000	98,652,000	97,788,000	110,489,000	105,498,000	102,189,000	104,303,000	110,012,000	105,221,000	92,469,000	98,378,000	91,602,000	91,144,000	89,312,000	96,040,000	87,512,000	98,236,000	91,727,000	86,931,000	86,435,000	87,255,000	88,737,000	94,115,000	88,757,000	81,509,000	87,653,000	95,182,000	82,933,000	71,443,000
long-term debt	634,934,000	1,543,698,000	1,359,710,000	1,355,148,000	1,450,994,000	1,420,952,000	1,142,079,000	1,167,167,000	1,082,933,000	1,087,948,000	1,076,537,000	1,117,167,000	1,050,337,000	284,014,000	1,126,070,000	1,110,826,000	1,146,550,000	1,155,456,000	1,126,258,000	1,105,022,000	1,217,680,000	1,036,882,000	1,031,626,000	980,911,000
finance lease obligations	34,943,000	35,577,000	36,268,000	38,845,000	39,335,000	39,676,000	839,196,000	836,309,000
operating lease obligations	159,711,000	2,199,826,000	2,476,384,000	2,632,831,000	2,681,403,000	2,697,496,000	2,250,790,000	2,279,493,000
liabilities held for sale	18,271,000	18,373,000	24,043,000	44,913,000	19,789,000	45,314,000	55,038,000	102,235,000	25,942,000	105,807,000	118,929,000	126,901,000				68,805,000	69,057,000
other long-term liabilities	141,765,000	200,165,000	99,305,000	64,704,000	69,905,000	76,125,000	82,478,000	90,879,000	126,247,000	99,559,000	101,494,000	118,323,000	119,484,000	133,854,000	138,963,000	145,966,000	103,435,000	105,070,000	130,898,000	133,769,000	133,111,000	132,553,000	127,605,000	129,428,000	12,660,000	12,641,000	12,471,000	12,296,000	12,367,000	12,480,000	14,259,000	15,047,000	15,477,000	15,605,000	17,503,000	17,935,000	17,773,000	16,499,000	16,446,000	16,923,000	15,984,000	16,933,000	16,035,000	12,478,000	12,426,000	12,694,000	14,405,000	14,117,000	14,064,000	15,413,000	23,077,000	24,496,000	21,810,000	21,277,000	20,168,000
commitments and contingencies
stockholders’ deficit:
class a common stock	111,000	111,000	111,000	108,000	108,000	108,000	107,000	104,000	101,000	101,000	101,000	98,000	97,000	94,000	80,000	77,000	75,000	74,000	74,000	74,000	74,000	74,000	74,000	74,000
class b common stock	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	14,000	16,000	16,000	16,000	16,000	16,000	16,000	16,000	16,000	16,000
class c common stock,	55,000	55,000	55,000	56,000	56,000	56,000	57,000	57,000	60,000	60,000	59,000	60,000	61,000	61,000	62,000	62,000	64,000	64,000	64,000	64,000	64,000	64,000
additional paid-in-capital	247,472,000	243,697,000	242,108,000	247,876,000	248,594,000	249,063,000	248,287,000	254,384,000	270,408,000	267,882,000	266,210,000	284,365,000	290,573,000	296,378,000	295,100,000	297,618,000	305,358,000	302,747,000	298,536,000	296,948,000	295,359,000	293,330,000	298,899,000		382,718,000	381,818,000	380,808,000	378,992,000	378,756,000	378,071,000	377,439,000	377,125,000	376,027,000	374,846,000	373,653,000	372,463,000	371,753,000	370,593,000	370,405,000	369,216,000	368,582,000	367,245,000	366,278,000	365,416,000	365,126,000	364,561,000	364,016,000	366,992,000	366,565,000	366,078,000	365,661,000	365,355,000	365,051,000	364,841,000	364,688,000
accumulated deficit	-1,069,259,000	-1,061,586,000	-998,793,000	-976,788,000	-1,010,296,000	-998,900,000	-1,044,997,000	-1,040,178,000	-1,609,828,000	-1,540,875,000	-1,482,747,000	-1,443,135,000	-1,374,597,000	-1,285,356,000	-911,532,000	-846,376,000	-795,615,000	-818,072,000	-797,614,000	-774,641,000	-731,602,000	-466,112,000	-437,160,000		-287,499,000	-287,435,000	-288,078,000	-285,297,000	-286,592,000	-283,589,000	-271,515,000	-273,038,000	-276,108,000	-281,803,000	-287,871,000	-287,751,000	-294,088,000	-301,018,000	-68,407,000	-78,978,000	-90,822,000	-101,663,000	-76,355,000	-80,900,000
accumulated other comprehensive income	1,396,000	1,503,000	1,591,000	1,243,000	602,000	610,000	541,000	135,000										81,000	379,000	272,000	-218,000	327,000	318,000	631,000				28,000	28,000	23,000	26,000										-218,000	-365,000		-224,000	40,000
total stockholders’ deficit before noncontrolling interests	-820,224,000	-816,219,000	-754,927,000	-727,504,000	-760,935,000	-749,062,000	-796,004,000	-785,497,000	-1,339,520,000	-1,273,396,000	-1,216,645,000	-1,159,187,000	-1,084,227,000	-988,956,000	-616,491,000	-548,818,000	-490,323,000	-515,090,000	-498,545,000	-477,267,000	-436,307,000	-172,301,000	-137,789,000
noncontrolling interests	-342,023,000	-328,696,000	-315,354,000	-314,631,000	-321,630,000	-316,161,000	-336,975,000	-339,464,000	-705,346,000	-665,335,000	-631,101,000	-627,543,000	-595,905,000	-539,763,000	-298,553,000	-262,705,000	-239,865,000	-256,441,000	-224,163,000	-210,956,000	-183,080,000	-134,095,000	-106,753,000
total stockholders' deficit	-1,162,247,000	-1,144,915,000	-1,070,281,000	-1,042,135,000	-1,082,565,000	-1,065,223,000	-1,132,979,000	-1,124,961,000	-2,044,866,000	-1,938,731,000	-1,847,746,000	-1,786,730,000	-1,680,132,000	-1,528,719,000	-915,044,000	-811,523,000	-730,188,000	-771,531,000	-722,708,000	-688,223,000	-619,387,000	-306,396,000	-244,542,000
total liabilities and stockholders’ deficit	4,062,246,000	4,214,625,000	4,366,334,000	4,488,981,000	4,662,140,000	4,674,147,000	4,642,580,000	4,779,923,000	4,263,623,000	4,391,374,000	4,544,817,000	4,771,539,000	4,787,865,000	4,926,928,000	5,514,788,000	5,688,509,000	5,779,201,000	5,886,587,000	5,933,018,000	6,005,750,000	6,091,470,000	6,121,361,000	6,103,378,000	6,031,356,000
finance lease right-of-use assets, net of accumulated amortization of 15,578 and 23,401 at september 30, 2020 and december 31, 2019, respectively		28,635,000
identifiable intangible assets, net of accumulated amortization of 80,126 and 76,243 at september 30, 2020 and december 31, 2019, respectively		83,530,000
finance lease right-of-use assets, net of accumulated amortization of 20,652 and 23,401 at june 30, 2020 and december 31, 2019, respectively			32,956,000
identifiable intangible assets, net of accumulated amortization of 78,864 and 76,243 at june 30, 2020 and december 31, 2019, respectively			84,826,000
finance lease right-of-use assets, net of accumulated amortization of 24,436 and 23,401 at march 31, 2020 and december 31, 2019, respectively				33,791,000
identifiable intangible assets, net of accumulated amortization of 77,553 and 76,243 at march 31, 2020 and december 31, 2019, respectively				86,136,000
current installments of long-term debt				106,088,000	162,426,000	121,745,000	108,639,000	89,695,000	122,531,000	116,077,000	107,338,000	30,082,000	26,962,000	851,344,000	23,770,000	36,062,000	24,594,000	30,758,000	8,328,000	8,113,000	12,477,000	12,453,000	12,889,000	12,746,000
current installments of finance lease obligations				2,926,000	2,839,000	2,738,000	2,678,000	2,734,000
current installments of operating lease obligations				142,191,000	140,887,000	137,574,000	110,156,000	107,497,000
finance lease right-of-use assets, net of accumulated amortization of 23,401 at december 31, 2019					37,097,000
identifiable intangible assets, net of accumulated amortization of 76,243 and 99,160 at december 31, 2019 and december 31, 2018, respectively					87,446,000
current installments of financing obligations
financing obligations									2,001,000	1,947,000	1,983,000	1,930,000	1,878,000	2,908,020,000	1,777,000	1,660,000	1,613,000	1,566,000	1,431,000	1,230,000	989,000	1,026,000	1,062,000	1,098,000
finance lease right-of-use assets, net of accumulated amortization of 22,420 at september 30, 2019						37,685,000
identifiable intangible assets, net of accumulated amortization of 73,610 and 99,160 at september 30, 2019 and december 31, 2018, respectively						90,079,000
finance lease right-of-use assets, net of accumulated amortization of 65,889 at june 30, 2019							516,537,000
identifiable intangible assets, net of accumulated amortization of 70,992 and 99,160 at june 30, 2019 and december 31, 2018, respectively							92,397,000
finance lease right-of-use assets, net of accumulated amortization of 66,460 at march 31, 2019								523,167,000
identifiable intangible assets, net of accumulated amortization of 68,374 and 99,160 at march 31, 2019 and december 31, 2018, respectively								95,015,000
identifiable intangible assets, net of accumulated amortization of 99,160 and 88,336 at december 31, 2018 and december 31, 2017, respectively									119,082,000
capital lease obligations									2,171,000	2,164,000	2,159,000	2,411,000	2,511,000	949,050,000	3,464,000	1,926,000	1,886,000	1,852,000	1,849,000	1,847,000	1,842,000	1,843,000	1,826,000	3,004,000
accumulated other comprehensive loss									-262,000	-565,000	-269,000	-576,000	-362,000	-134,000	-215,000	-215,000	-221,000															-47,000	-127,000	-211,000	-300,000	-388,000	-490,000	-519,000	-417,000	-207,000						-623,000	-1,127,000	-1,503,000	-1,842,000	-887,000	-997,000	-2,156,000	-753,000
identifiable intangible assets, net of accumulated amortization of 97,242 and 88,336 at september 30, 2018 and december 31, 2017, respectively										125,386,000
identifiable intangible assets, net of accumulated amortization of 94,369 and 88,336 at june 30, 2018 and december 31, 2017, respectively											131,091,000
investments in marketable securities												30,677,000
identifiable intangible assets, net of accumulated amortization of 93,127 and 88,336 at march 31, 2018 and december 31, 2017, respectively												138,186,000
restricted cash and investments in marketable securities													37,128,000	43,965,000	43,965,000	43,550,000	43,555,000	41,252,000	52,577,000	52,917,000	52,917,000	51,449,000	50,111,000	52,234,000
identifiable intangible assets, net of accumulated amortization of 88,336 and 91,155 at december 31, 2017 and december 31, 2016, respectively													142,976,000
identifiable intangible assets, net of accumulated amortization of 84,073 and 91,155 at september 30, 2017 and december 31, 2016, respectively														147,239,000
identifiable intangible assets, net of accumulated amortization of 104,378 and 91,155 at june 30, 2017 and december 31, 2016, respectively															162,344,000
identifiable intangible assets, net of accumulated amortization of 97,929 and 91,155 at march 31, 2017 and december 31, 2016, respectively																168,793,000
identifiable intangible assets, net of accumulated amortization of 91,155 and 66,570 at december 31, 2016 and december 31, 2015, respectively																	175,566,000
identifiable intangible assets, net of accumulated amortization of 87,033 and 66,570 at september 30, 2016 and december 31, 2015, respectively																		185,779,000
identifiable intangible assets, net of accumulated amortization of 80,250 and 66,570 at june 30, 2016 and december 31, 2015, respectively																			192,566,000
identifiable intangible assets, net of accumulated amortization of 73,458 and 66,570 at march 31, 2016 and december 31, 2015, respectively																				203,080,000
identifiable intangible assets, net of accumulated amortization of 66,570 and 42,661 at december 31, 2015 and december 31, 2014, respectively																					209,967,000
identifiable intangible assets, net of accumulated amortization of 62,550 and 42,661 at september 30, 2015 and december 31, 2014																						219,028,000
identifiable intangible assets, net of accumulated amortization of 55,743 and 42,661 at june 30, 2015 and december 31, 2014																							225,945,000
class c common stock																							64,000	64,000
cash and equivalents																								95,708,000
identifiable intangible assets, net of accumulated amortization of 48,507 at march 31, 2015 and 42,661 at december 31, 2014																								233,181,000
liabilities and stockholders’ deficit:
additional paid-in capital																								298,369,000
total stockholders’ deficit
assets
accounts receivables																									124,103,000	114,598,000	110,443,000	109,407,000	107,215,000	107,109,000	122,280,000	112,505,000	107,245,000	109,152,000	108,792,000	110,013,000	99,764,000	102,095,000	104,233,000	107,904,000	98,777,000	94,771,000	98,370,000	98,188,000	96,610,000	101,528,000	101,124,000	119,423,000	115,211,000	113,496,000	111,215,000	126,208,000	112,919,000	101,438,000	89,696,000
property and equipment, less accumulated depreciation of 160,984 and 137,484 at december 31, 2014 and december 31, 2013, respectively																									331,130,000
leased facility assets, less accumulated depreciation of 4,904 and 4,432 at december 31, 2014 and december 31, 2013, respectively																									8,944,000
other assets:
notes receivable																									1,800,000	2,117,000	2,350,000	131,000	520,000	784,000	1,276,000	1,531,000	2,055,000	2,886,000	3,952,000	4,349,000	5,092,000	5,862,000	6,626,000	6,445,000	5,877,000	6,675,000	8,109,000	7,247,000	8,060,000	9,440,000	11,496,000	7,801,000	4,448,000	4,838,000	5,205,000	4,875,000	5,102,000	5,533,000	5,992,000
deferred financing costs																									7,318,000	8,043,000	8,600,000	8,470,000	9,189,000	8,060,000	6,394,000	5,717,000	6,355,000	6,995,000	7,437,000	9,013,000	9,837,000	10,688,000	11,514,000	12,339,000	13,165,000	13,991,000	15,127,000	12,004,000	13,425,000	14,847,000	16,268,000	9,390,000	10,184,000	10,977,000	11,771,000	12,566,000	11,869,000	12,504,000	12,768,000
intangible assets, less accumulated amortization of 4,957 and 4,640 at december 31, 2014 and december 31, 2013, respectively																									18,491,000
other assets																									49,825,000	15,747,000	15,199,000	45,376,000	42,708,000	42,060,000	41,581,000	38,588,000	39,737,000	36,565,000	36,701,000	34,766,000	32,119,000	34,351,000	32,984,000	33,073,000	24,476,000	24,791,000	25,555,000	25,691,000	24,284,000	25,326,000	24,111,000	25,473,000	23,797,000	23,432,000	23,102,000	23,536,000	22,461,000	21,663,000	20,431,000
total other assets																									149,499,000	149,917,000	151,055,000	150,464,000	149,761,000	149,144,000	160,182,000	159,580,000	163,153,000	163,670,000	166,299,000	165,257,000	165,375,000	157,442,000	409,012,000	410,027,000	401,583,000	410,154,000	414,300,000	349,788,000	351,428,000	526,775,000	530,174,000	521,949,000	518,701,000	522,936,000	527,171,000	527,401,000	525,522,000	527,164,000	493,862,000
liabilities and stockholders’ equity
accounts payable and accrued liabilities																									65,349,000	64,739,000	57,868,000	51,250,000	57,179,000	53,660,000	50,799,000	51,967,000	48,780,000	58,018,000	53,192,000	51,556,000	52,897,000	49,259,000	48,772,000	48,002,000	50,898,000	46,526,000	58,312,000	53,809,000	49,355,000	45,068,000	51,605,000	49,256,000	55,478,000	45,373,000	49,265,000	55,645,000	59,218,000	50,721,000	46,752,000
employee compensation and benefits																									37,487,000	42,201,000	41,385,000	37,230,000	32,979,000	39,383,000	42,393,000	36,762,000	42,185,000	37,501,000	40,104,000	35,640,000	41,067,000	36,056,000	35,784,000	34,621,000	39,400,000	32,691,000	30,535,000	28,987,000	29,753,000	31,372,000	32,193,000	31,698,000	30,825,000	33,106,000	29,056,000	27,835,000	29,629,000	25,618,000	21,734,000
long-term liabilities:
insurance liability risks																									29,356,000	28,075,000	29,232,000	31,027,000	29,534,000	27,035,000	26,020,000	24,994,000	27,396,000	27,051,000	29,437,000	31,442,000	30,567,000	30,846,000	32,588,000	33,546,000	25,474,000	25,313,000	25,130,000	26,283,000	27,407,000	29,898,000	30,223,000	31,369,000	30,654,000	32,799,000	32,755,000	31,104,000	24,248,000	27,149,000	26,779,000
long-term debt, less current portion																									398,389,000	394,644,000	400,036,000	409,076,000	411,495,000	417,363,000	433,207,000	438,206,000	435,629,000	439,047,000	451,452,000	470,273,000	471,069,000	485,847,000	486,639,000
total liabilities																									555,697,000	555,473,000	551,190,000	551,051,000	551,184,000	567,367,000	578,984,000	580,436,000	582,805,000	591,715,000	603,613,000	612,119,000	617,787,000	624,794,000	637,396,000	651,042,000	660,150,000	670,081,000	636,498,000	574,690,000	580,820,000	595,278,000	608,886,000	606,488,000	601,739,000	604,996,000	600,058,000	604,659,000	595,638,000	584,234,000	523,981,000
commitments and contingencies — note 13
stockholders’ equity:
class a common stock, 175,000 shares authorized, 0.001 par value per share...																									24,000	25,000	25,000	24,000	24,000	24,000	24,000	24,000	23,000	23,000	22,000	22,000	21,000	21,000	21,000	21,000	21,000	21,000	21,000	21,000	20,000	20,000	20,000	20,000	20,000	20,000	19,000	19,000	19,000	19,000
class b common stock, 30,000 shares authorized, 0.001 par value per share...																									16,000	16,000	16,000	16,000	16,000	16,000	16,000	16,000	16,000	16,000	16,000	17,000	17,000	17,000	17,000	17,000	17,000	17,000	17,000	17,000	17,000	17,000	17,000	17,000	17,000	17,000	18,000	18,000	18,000	18,000
total stockholders’ equity																									95,259,000	94,424,000	92,771,000	93,763,000	92,232,000	94,545,000	105,990,000	104,080,000	99,831,000	92,871,000	85,520,000	84,363,000	77,213,000	69,094,000	301,619,000	290,069,000	277,580,000	265,255,000	289,961,000	284,330,000	275,422,000	435,508,000	425,408,000	423,736,000	412,103,000	402,306,000	392,203,000	381,814,000	374,469,000	367,822,000	360,811,000
total liabilities and stockholders’ equity																									650,956,000	649,897,000	643,961,000	644,814,000	643,416,000	661,912,000	684,974,000	684,516,000	682,636,000	684,586,000	689,133,000	696,482,000	695,000,000	693,888,000	939,015,000	941,111,000	937,730,000	935,336,000	926,459,000	859,020,000	856,242,000	1,030,786,000	1,034,294,000	1,030,224,000	1,013,842,000	1,007,302,000	992,261,000	986,473,000	970,107,000	952,056,000	884,792,000
property and equipment, less accumulated depreciation of 155,097 and 137,484 at september 30, 2014 and december 31, 2013, respectively																										333,285,000
leased facility assets, less accumulated depreciation of 4,791 and 4,432 at september 30, 2014 and december 31, 2013, respectively																										9,057,000
intangible assets, less accumulated amortization of 4,879 and 4,640 at september 30, 2014 and december 31, 2013, respectively																										18,569,000
restricted assets																										31,462,000	30,246,000
commitments and contingencies — note 8
property and equipment, less accumulated depreciation of 149,175 and 137,484 at june 30, 2014 and december 31, 2013, respectively																											336,360,000
leased facility assets, less accumulated depreciation of 4,674 and 4,432 at june 30, 2014 and december 31, 2013, respectively																											9,174,000
intangible assets, less accumulated amortization of 4,799 and 4,640 at june 30, 2014 and december 31, 2013, respectively																											18,648,000
property and equipment, less accumulated depreciation of 143,366 and 137,484 at march 31, 2014 and december 31, 2013, respectively																												339,490,000
leased facility assets, less accumulated depreciation of 4,555 and 4,432 at march 31, 2014 and december 31, 2013, respectively																												9,293,000
intangible assets, less accumulated amortization of 4,720 and 4,640 at march 31, 2014 and december 31, 2013, respectively																												18,728,000
property and equipment, less accumulated depreciation of 137,484 and 118,141 at december 31, 2013 and december 31, 2012, respectively																													341,822,000
leased facility assets, less accumulated depreciation of 4,432 and 3,935 at december 31, 2013 and december 31, 2012, respectively																													9,416,000
intangible assets, less accumulated amortization of 4,640 and 4,218 at december 31, 2013 and december 31, 2012, respectively																													18,807,000
property and equipment, less accumulated depreciation of 135,885 and 118,141 at september 30, 2013 and december 31, 2012, respectively																														362,908,000
leased facility assets, less accumulated depreciation of 4,310 and 3,935 at september 30, 2013 and december 31, 2012, respectively																														9,538,000
intangible assets, less accumulated amortization of 4,465 and 4,218 at september 30, 2013 and december 31, 2012, respectively																														18,983,000
commitments and contingencies — note 7
property and equipment, less accumulated depreciation of 129,990 and 118,141 at june 30, 2013 and december 31, 2012, respectively																															364,877,000
leased facility assets, less accumulated depreciation of 4,186 and 3,935 at june 30, 2013 and december 31, 2012, respectively																															9,662,000
intangible assets, less accumulated amortization of 4,382 and 4,218 at june 30, 2013 and december 31, 2012, respectively																															21,871,000
property and equipment, less accumulated depreciation of 124,068 and 118,141 at march 31, 2013 and december 31, 2012, respectively																																367,219,000
leased facility assets, less accumulated depreciation of 4,062 and 3,935 at march 31, 2013 and december 31, 2012, respectively																																9,786,000
intangible assets, less accumulated amortization of 4,300 and 4,218 at march 31, 2013 and december 31, 2012, respectively																																21,953,000
property and equipment, less accumulated depreciation of 118,141 and 95,954 at december 31, 2012 and december 31, 2011, respectively																																	370,745,000
leased facility assets, less accumulated depreciation of 3,935 and 3,398 at december 31, 2012 and december 31, 2011, respectively																																	9,913,000
intangible assets, less accumulated amortization of 4,218 and 7,060 at december 31, 2012 and december 31, 2011, respectively																																	22,035,000
property and equipment, less accumulated depreciation of 112,885 and 95,954 at september 30, 2012 and december 31, 2011, respectively																																		369,716,000
leased facility assets, less accumulated depreciation of 3,805 and 3,398 at september 30, 2012 and december 31, 2011, respectively																																		10,043,000
intangible assets, less accumulated amortization of 4,131 and 7,060 at september 30, 2012 and december 31, 2011, respectively																																		22,122,000
property and equipment, less accumulated depreciation of 107,090 and 95,954 at june 30, 2012 and december 31, 2011, respectively																																			370,266,000
leased facility assets, less accumulated depreciation of 3,670 and 3,398 at june 30, 2012 and december 31, 2011, respectively																																			10,178,000
intangible assets, less accumulated amortization of 4,034 and 7,060 at june 30, 2012 and december 31, 2011, respectively																																			22,219,000
property and equipment, less accumulated depreciation of 101,844 and 95,954 at march 31, 2012 and december 31, 2011, respectively																																				373,412,000
leased facility assets, less accumulated depreciation of 3,535 and 3,398 at march 31, 2012 and december 31, 2011, respectively																																				10,313,000
intangible assets, less accumulated amortization of 3,937 and 7,060 at march 31, 2012 and december 31, 2011, respectively																																				22,316,000
property and equipment, less accumulated depreciation of 95,954 and 76,017 at december 31, 2011 and december 31, 2010, respectively																																					375,502,000
leased facility assets, less accumulated depreciation of 3,398 at december 31, 2011																																					10,792,000
intangible assets, less accumulated amortization of 7,060 and 15,646 at december 31, 2011 and december 31, 2010, respectively																																					22,413,000
deferred income tax assets																																					11,615,000
property and equipment, less accumulated depreciation of 90,165 and 76,017 at september 30, 2011 and december 31, 2010, respectively																																						376,290,000
leased facility assets, less accumulated depreciation of 3,283 at september 30, 2011																																						10,869,000
intangible assets, less accumulated amortization of 6,772 and 15,646 at september 30, 2011 and december 31, 2010, respectively																																						22,452,000
property and equipment, less accumulated depreciation of 84,431 and 76,017 at june 30, 2011 and december 31, 2010, respectively																																							370,284,000
leased facility assets, less accumulated depreciation of 3,144 at june 30, 2011																																							11,009,000
intangible assets, less accumulated amortization of 6,488 and 15,646 at june 30, 2011 and december 31, 2010, respectively																																							25,164,000
property and equipment, less accumulated depreciation of 81,787 and 76,017 at march 31, 2011 and december 31, 2010, respectively																																								383,429,000
intangible assets, less accumulated amortization of 6,206 and 15,646 at march 31, 2011 and december 31, 2010, respectively																																								25,446,000
current portion of long-term debt and capital leases																																								6,689,000	5,742,000	8,295,000	9,389,000	8,931,000	7,823,000	9,995,000	3,457,000	7,783,000	7,812,000	10,278,000	3,188,000	4,173,000	6,335,000	6,594,000	2,957,000
long-term debt and capital leases, less current portion																																								501,430,000	514,221,000	536,010,000	492,797,000	441,014,000	450,856,000	462,518,000	475,180,000	471,643,000	462,449,000	468,027,000	462,717,000	461,406,000	452,101,000	452,875,000	405,591,000
property and equipment, less accumulated depreciation of 76,017 and 59,448 at december 31, 2010 and december 31, 2009, respectively																																									387,322,000
intangible assets, less accumulated amortization of 15,646 and 14,413 at december 31, 2010 and december 31, 2009, respectively																																									25,341,000
property and equipment, less accumulated depreciation of 75,072 and 59,448 at september 30, 2010 and december 31, 2009, respectively																																										380,662,000
intangible assets, less accumulated amortization of 15,875 and 14,413 at september 30, 2010 and december 31, 2009, respectively																																										28,293,000
property and equipment, less accumulated depreciation of 69,615 and 59,448 at june 30, 2010 and december 31, 2009, respectively																																											381,386,000
intangible assets, less accumulated amortization of 15,063 and 14,413 at june 30, 2010 and december 31, 2009, respectively																																											29,105,000
property and equipment, less accumulated depreciation of 64,564 and 59,448 at march 31, 2010 and december 31, 2009, respectively																																												377,793,000
intangible assets, less accumulated amortization of 15,241 and 14,413 at march 31, 2010 and december 31, 2009, respectively																																												25,484,000
property and equipment, less accumulated depreciation of 59,448 and 40,118 at december 31, 2009 and december 31, 2008, respectively																																													373,211,000
intangible assets, less accumulated amortization of 14,413 and 10,490 at december 31, 2009 and december 31, 2008, respectively																																													26,297,000
(accumulated deficit) retained earnings																																													-89,781,000
property and equipment, less accumulated depreciation of 54,416 and 40,118 at september 30, 2009 and december 31, 2008, respectively																																														362,910,000
intangible assets, less accumulated amortization of 13,495 and 10,490 at september 30, 2009 and december 31, 2008, respectively																																														27,200,000
retained earnings																																														71,533,000	62,482,000	58,210,000	47,343,000	37,078,000	27,502,000	18,578,000	10,134,000	2,944,000
property and equipment, less accumulated depreciation of 49,448 and 40,118 at june 30, 2009 and december 31, 2008, respectively																																															357,669,000
intangible assets, less accumulated amortization of 12,493 and 10,490 at june 30, 2009 and december 31, 2008, respectively																																															28,337,000
property and equipment, less accumulated depreciation of 44,585 and 40,118 at march 31, 2009 and december 31, 2008, respectively																																																352,358,000
intangible assets, less accumulated amortization of 11,492 and 10,490 at march 31, 2009 and december 31, 2008, respectively																																																29,323,000
property and equipment, less accumulated depreciation of 40,118 and 23,519 at december 31, 2008 and 2007, respectively																																																	346,466,000
intangible assets, less accumulated amortization of 10,490 and 6,840 at december 31, 2008 and 2007, respectively																																																	30,310,000
non-current income tax receivable																																																			2,288,000	2,288,000	2,288,000	1,882,000	1,882,000
deferred income tax																																																	457,000				2,297,000
deferred income taxes, current																																																		13,861,000	13,248,000
property and equipment, less accumulated depreciation of 35,674 and 23,519 at september 30, 2008 and december 31, 2007 respectively																																																		335,854,000
intangible assets, less accumulated amortization of 9,490 and 6,840 at september 30, 2008 and december 31,2007 respectively																																																		31,145,000
non-current income taxes receivable																																																		2,288,000
deferred income taxes, non-current																																																		67,000	1,153,000
preferred stock, 25,000 shares authorized, 0.001 par value per share...
intangible assets																																																			31,941,000	32,838,000	34,092,000	35,408,000	32,565,000
deferred income tax, non-current
preferred stock, no shares authorized at december 31, 2007 and 50 shares authorized, 25 shares class a convertible shares and 25 class b shares at december 31, 2006
class a, 0.001 par value per share...
class b, 0.001 par value per share...
common stock, no shares authorized at december 31, 2007 and 25,350 shares authorized, 0.001 par value per share...
preferred stock, no shares authorized at september 30, 2007 (unaudited) and 50 shares authorized, 25 shares class a convertible shares and 25 class b shares at december 31, 2006
common stock, no shares authorized at september 30, 2007 (unaudited) and 25,350 shares authorized, 0.001 par value per share...
preferred stock, 50,000 shares authorized, 25,000 class a convertible shares and 25,000 class b shares.
preferred stock, 25,000,000 shares authorized, 0.001 par value per share...
common stock, 25,350,000 shares authorized, 0.001 par value per share...
class a common stock, 175,000,000 shares authorized, 0.001 par value per share...																																																							19,000
class b common stock, 30,000,000 shares authorized, 0.001 par value per share...																																																							18,000
retained deficit																																																							-3,914,000

Cashflow Statements:

Quarterly

Annual

Unit: USD	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30

cash flows from operating activities
net income	-16,802,000	-95,930,000	-29,316,000	38,681,000	-17,359,000				-108,986,000			-108,673,000	-155,017,000			-83,613,000			-35,958,000	-71,028,000	-312,640,000	-60,942,000			-64,000	643,000	-2,781,000	1,295,000	-3,002,000	-12,075,000	1,523,000	3,070,000	5,695,000	6,068,000	3,497,000	6,337,000	6,930,000	-232,611,000	10,571,000	11,844,000	10,841,000	-25,308,000	4,545,000	8,881,000	-161,316,000	9,053,000	8,215,000	10,867,000	10,265,000	9,576,000	8,924,000	8,444,000	7,184,000	6,864,000
adjustments to reconcile net income to net cash from operating activities:
non-cash interest and leasing arrangements	6,695,000	6,424,000	6,023,000	5,901,000	6,117,000	7,376,000	8,596,000	5,222,000	17,065,000	16,112,000	16,138,000	22,878,000		18,827,000	15,835,000	16,387,000		22,589,000	22,650,000	24,989,000	24,275,000	21,920,000	24,192,000	23,413,000
other non-cash gain	-19,834,000	-53,507,000	-44,100,000	-84,832,000	-1,364,000	-131,811,000
share based compensation	1,155,000	1,600,000	1,831,000	1,894,000	1,596,000	1,878,000	1,748,000	2,087,000	2,088,000	2,175,000	2,130,000	2,427,000		2,439,000	2,481,000	2,286,000		3,579,000	1,590,000	1,590,000	620,000	1,949,000	530,000	25,373,000
depreciation and amortization expense	23,656,000	24,373,000	33,816,000	25,988,000	21,764,000	34,932,000	28,268,000	38,195,000	52,860,000	53,038,000
reduction in the carrying amount of operating lease right-of-use assets	25,106,000	25,152,000	31,561,000	31,506,000
recovery for losses on accounts receivable	-523,000
equity in net income of unconsolidated affiliates	-1,358,000	-3,362,000	-3,576,000	127,000										-69,000	-88,000	-134,000		-893,000	-497,000	-763,000		-640,000
benefit for deferred taxes	-293,000	3,051,000	-422,000	-1,331,000	1,595,000	-660,000			-1,170,000									-25,955,000	-417,000	4,415,000
loss on early extinguishment of debt	1,812,000	260,000	354,000	1,328,000		367,000				0	0	9,300,000		0				12,246,000
long-lived asset impairments	19,800,000	72,400,000	77,100,000	9,700,000	0	16,037,000			16,989,000	32,391,000	27,257,000	28,360,000
changes in assets and liabilities:
accounts receivable	13,347,000	6,193,000	98,650,000	7,321,000	-18,869,000	3,199,000	40,441,000	20,974,000	17,841,000	25,681,000	23,856,000	-870,000		-35,671,000	-12,178,000	-4,723,000		-33,305,000	-42,212,000	-60,866,000	-42,398,000	-23,531,000			-13,268,000	-7,892,000	-7,538,000	-5,105,000	-5,968,000	12,509,000	-12,888,000	-8,149,000	-320,000	-2,172,000	-661,000	-12,140,000	2,509,000	-428,000	1,734,000	-13,114,000	-6,646,000	1,157,000	-4,984,000	-4,035,000	904,000	-1,629,000	-3,789,000	-11,322,000	-4,900,000	-5,658,000	9,607,000	-14,717,000	-14,123,000	-12,701,000
accounts payable and other accrued expenses and other	6,703,000	-19,806,000	24,374,000	7,277,000	-13,725,000	-12,322,000	-32,105,000	-18,759,000	-9,861,000	-21,898,000	-30,131,000	-10,026,000		15,069,000	-3,000,000	16,563,000		4,373,000	-1,267,000	37,839,000	11,901,000	-5,277,000	-22,000,000	44,606,000
medicare advance payments	0	-999,000
operating lease obligations	-24,891,000	-25,167,000	-27,610,000	-28,511,000	-26,999,000	-24,586,000	-20,478,000	-21,567,000
net cash from operating activities	34,573,000	-59,439,000	325,347,000	15,250,000	-22,924,000	-20,323,000	23,935,000	12,146,000	4,518,000	2,597,000	17,556,000	-6,087,000	53,097,000	-1,769,000	24,497,000	44,630,000	33,059,000	11,787,000	-931,000	24,446,000	13,567,000	2,780,000			-5,138,000	10,245,000	15,477,000	5,737,000	11,089,000	23,043,000	9,308,000	4,481,000	11,740,000	16,816,000	15,142,000	-1,022,000	33,189,000	20,961,000	33,355,000	11,875,000	31,160,000	-34,373,000	20,373,000	18,138,000	29,490,000	16,631,000	20,812,000	7,964,000	20,340,000	15,967,000	24,670,000	2,036,000	16,240,000	6,547,000
cash flows from investing activities:
capital expenditures	-13,576,000	-9,944,000	-10,818,000	-21,278,000	-15,681,000	-10,496,000	-13,021,000	-23,529,000	-9,831,000	-14,170,000	-10,690,000	-16,461,000	-15,641,000	-14,624,000	-14,596,000	-19,245,000	-22,328,000	-22,893,000	-21,654,000	-26,243,000	-20,230,000	-28,635,000			-3,738,000	-2,982,000	-2,711,000	-3,550,000	-3,459,000	-3,996,000	-3,580,000	-2,401,000	-7,009,000	-5,416,000	-3,622,000	-3,475,000	-5,182,000	-4,893,000	-3,656,000	-2,567,000	-4,575,000	-4,769,000	-8,694,000	-9,698,000	-11,973,000	-10,255,000	-8,499,000	-10,428,000	-15,156,000	-13,226,000	-12,311,000	-8,933,000	-9,000,000	-7,771,000
free cash flows	20,997,000	-69,383,000	314,529,000	-6,028,000	-38,605,000	-30,819,000	10,914,000	-11,383,000	-5,313,000	-11,573,000	6,866,000	-22,548,000	37,456,000	-16,393,000	9,901,000	25,385,000	10,731,000	-11,106,000	-22,585,000	-1,797,000	-6,663,000	-25,855,000			-8,876,000	7,263,000	12,766,000	2,187,000	7,630,000	19,047,000	5,728,000	2,080,000	4,731,000	11,400,000	11,520,000	-4,497,000	28,007,000	16,068,000	29,699,000	9,308,000	26,585,000	-39,142,000	11,679,000	8,440,000	17,517,000	6,376,000	12,313,000	-2,464,000	5,184,000	2,741,000	12,359,000	-6,897,000	7,240,000	-1,224,000
purchases of marketable securities	-24,795,000	-18,303,000	-23,828,000	-12,359,000	-22,420,000	-20,627,000	-12,569,000	-14,700,000	-16,116,000	-23,491,000	-24,034,000	-16,009,000		-6,354,000	-8,278,000	-8,039,000		-3,853,000	-21,070,000	-13,922,000	-56,397,000	-5,683,000
proceeds on maturity or sale of marketable securities	8,604,000	12,291,000	23,569,000	19,416,000	14,449,000	36,208,000	12,260,000	8,257,000	18,267,000	17,828,000	17,383,000	15,702,000		30,998,000	7,291,000	7,921,000		6,740,000	32,809,000	13,465,000	21,611,000	2,280,000	7,265,000	10,158,000
purchases of assets	0	-197,467,000	-700,000	-9,146,000	0	-339,185,000	0	-252,475,000														-1,895,000
sales of assets	40,878,000	10,791,000	46,437,000	161,408,000	20,174,000	103,259,000	55,373,000	79,000,000						-36,000				1,051,000				0	0	1,263,000
restricted deposits	-138,000			749,000	-2,596,000	0												-2,253,000
investments in joint venture	-584,000	-50,000	-2,000,000	-14,886,000														76,000
loan provided to joint venture	0	0	0	-9,000,000
notes receivable and other investment additions
other	1,653,000	-2,404,000	-245,000	32,000	-485,000	15,000	392,000	28,000	58,000	38,000	126,000	-1,099,000		-575,000	628,000	-537,000		1,491,000	1,997,000	-366,000	484,000	1,695,000	-951,000	912,000
net cash from investing activities	12,042,000	-192,176,000	31,666,000	114,936,000	6,031,000	-230,826,000	41,211,000	-203,419,000	66,753,000	-19,795,000	-17,215,000	-17,867,000		6,929,000	63,772,000	-21,301,000		-37,862,000	-19,293,000	58,117,000	-185,551,000	-39,066,000	-35,157,000	6,290,000	-3,738,000	-2,886,000	-1,651,000	-3,550,000	9,484,000	-3,996,000	-3,580,000	-2,401,000	-7,009,000	-5,416,000	-3,625,000	-3,475,000	-15,204,000	-18,540,000	-3,656,000	-2,517,000	-7,864,000	-4,769,000	-54,074,000	-9,698,000	-15,336,000	-11,839,000	-7,297,000	-11,696,000	-14,731,000	-19,609,000	-25,248,000	-8,789,000	-10,468,000	-59,142,000
cash flows from financing activities:
borrowings under revolving credit facilities	1,014,900,000	1,046,420,000	1,391,198,000	1,093,643,000	1,139,000,000	1,150,000,000	1,209,000,000	1,163,000,000	1,604,439,000	1,239,716,000	1,307,284,000	440,000,000
repayments under revolving credit facilities	-1,014,900,000	-1,046,420,000	-1,477,110,000	-1,143,692,000	-1,112,199,000	-1,135,531,000	-1,188,258,000	-1,194,676,000	-1,588,940,000	-1,233,420,000	-1,280,706,000	-445,749,000
proceeds from issuance of long-term debt	854,000	193,828,000	26,693,000	7,339,000	57,632,000	310,341,000	0	170,565,000	10,424,000	1,361,000	492,000	561,894,000		6,392,000				171,151,000	115,114,000	67,872,000	134,100,000	1,101,000	0	360,000,000					69,805,000				0	0
repayment of long-term debt	-24,292,000	-25,997,000	-51,838,000	-89,654,000	-65,713,000	-43,947,000	-85,499,000	-4,467,000	-82,014,000	-4,639,000	-6,255,000	-451,169,000		-10,399,000	-95,305,000	-4,094,000		-172,990,000	-136,216,000	-127,717,000	-6,296,000	-9,527,000
repayment of finance lease obligations	-728,000	-735,000	-730,000	-712,000	-672,000	-702,000	-696,000	-575,000
debt issuance and settlement costs
contributions from noncontrolling interests	544,000				0	8,531,000	0	18,500,000
distributions to noncontrolling interests and stockholders	-2,086,000	-1,334,000	-1,164,000	-1,123,000	-1,561,000	-1,648,000	-1,406,000	-1,138,000	-652,000	-792,000	-566,000	-15,000		-1,222,000	-428,000	-30,000		-357,000	-300,000	-240,000
net cash from financing activities	-30,933,000	183,777,000	-113,190,000	-134,439,000	14,630,000	282,427,000	-66,859,000	147,501,000	-57,095,000	2,226,000			-55,254,000	-19,314,000	-75,317,000	-22,944,000	-21,741,000	33,237,000	14,698,000	-91,902,000	173,856,000	12,994,000	27,659,000	4,352,000	1,969,000	-4,783,000	-10,071,000	-2,159,000	-18,991,000	-18,471,000	-8,858,000	1,066,000	-5,927,000	-13,773,000	-15,826,000	-1,639,000	-18,410,000	-994,000	-15,624,000	-12,610,000		42,185,000	31,751,000	-9,861,000	-13,861,000	-14,121,000	-8,794,000	9,138,000	-7,889,000	4,256,000	299,000	5,733,000	-1,085,000	50,587,000
net increase in cash, cash equivalents and restricted cash and equivalents	15,682,000	-67,838,000			-2,263,000	31,278,000	-1,713,000	-43,772,000	14,176,000	-14,972,000	20,965,000	63,469,000
cash, cash equivalents and restricted cash and equivalents:
beginning of period	0	0	0	125,806,000	0	0	0	142,276,000	0	0	0	58,638,000		0	0	51,408,000		0	0	61,543,000	0	0	0	87,548,000
end of period	15,682,000	-67,838,000	243,823,000	121,553,000	-2,263,000	31,278,000	-1,713,000	98,504,000	14,176,000	-14,972,000	20,965,000	122,107,000		-14,154,000	12,952,000	51,793,000		7,162,000	-5,526,000	52,204,000	1,872,000	-23,292,000	-12,745,000	95,708,000
supplemental cash flow information:
interest paid	28,890,000	25,637,000	22,900,000	31,815,000	34,832,000	27,214,000	45,923,000	45,620,000	101,087,000	99,714,000	101,438,000	91,393,000		107,328,000	110,528,000	107,373,000		109,437,000	112,616,000	111,456,000	108,134,000	107,942,000	105,139,000	94,948,000
net taxes paid	441,000	573,000	466,000	1,430,000	-1,176,000	1,062,000	529,000	1,081,000	1,408,000	-1,085,000	1,020,000	3,084,000
federal and state stimulus - covid-19 other income
non-cash investing and financing activities:
finance lease obligations, net write-down due to lease activity	84,000	55,000			472,000	-798,740,000
assets subject to finance lease obligations, net write-down due to lease activity	-80,000	-29,000
operating lease obligations, net (write-down) gross-up due to lease activity	-70,357,000	-260,268,000
assets subject to operating leases, net write-down (gross-up) due to lease activity	60,835,000	222,382,000
financing obligations, net write-down due to lease activity					0	0
assets subject to financing obligations, net write-down due to lease activity					0	0
debt issuance costs		-3,165,000	-239,000	-240,000	-1,857,000	-4,617,000	0	-3,708,000	-352,000	0	-126,000	-16,552,000		-1,735,000				-7,615,000	-2,510,000	-2,316,000	-1,417,000	-1,000
federal stimulus - covid-19 other income		31,213,000
provision (recovery) for losses on accounts receivable			-161,000	201,000
net decrease in cash, cash equivalents and restricted cash and equivalents				-4,253,000
finance lease obligations, net gross up (write-down) due to lease activity				309,000
assets subject to finance lease obligations, net (gross-up) write-down due to lease activity				-310,000	1,077,764,000	-601,327,000
operating lease obligations, net gross-up due to lease activity				-18,757,000	14,218,000	493,242,000	0	2,408,557,000
assets subject to operating leases, net (gross-up) due to lease activity				14,320,000	-9,294,000	-249,712,000	0	-2,264,702,000
(recovery) provision for losses on accounts receivable
goodwill and identifiable intangible asset impairments									1,477,000	929,000
gain on early extinguishment of debt
notes receivable and other investment reductions
debt settlement costs									0	0	501,000	-986,000
operating lease right-of-use asset amortization						26,721,000	29,955,000	29,574,000
provision for losses on accounts receivable						-259,000	-61,000	-685,000																23,392,000
equity in net loss of unconsolidated affiliates						-93,000	-24,000	-61,000
net loss							-8,983,000	-25,082,000																-118,250,000
adjustments to reconcile net loss to net cash from operating activities:
other non-cash (gains) charges								-16,917,000	29,440,000	-20,208,000
provision for deferred taxes								-835,000
finance lease obligations, net (write-down) gross-up due to lease activity								-131,842,000
assets subject to finance lease obligations, net write-down (gross-up) due to lease activity								61,512,000
financing obligations, net (write-down) gross-up due to lease activity								-2,734,940,000	8,008,000
assets subject to financing obligations, net write-down (gross-up) due to lease activity								1,718,507,000	2,792,000
benefit from losses on accounts receivable									-3,625,000			-1,524,000				23,528,000			29,681,000	26,493,000	31,692,000	23,320,000
customer receivership and other related charges
proceeds from tenant improvement draws under lease arrangements														0	903,000	5,180,000		48,000	610,000	499,000	887,000	1,938,000	0	95,000
capital lease obligations, net (write-down) gross-up due to lease activity									14,135,000
assets subject to capital lease obligations, net write-down (gross-up) due to lease activity									-14,135,000
equity in net income (income) of unconsolidated affiliates												220,000
capital lease obligations and assets
financing obligations											-130,935,000	5,152,000		7,019,000	2,527,000	8,733,000		21,005,000	4,067,000	3,861,000	56,489,000	1,021,000	22,797,000	3,682,000
financing obligation assets
other non-cash charges												68,000				9,034,000
depreciation and amortization												51,503,000		59,390,000	60,227,000	64,369,000		61,104,000	67,953,000	61,765,000	61,576,000	62,494,000	53,616,000	60,077,000	5,994,000	6,120,000	6,035,000	6,085,000	6,226,000	6,130,000	6,047,000	6,219,000	6,276,000	6,258,000	6,591,000	6,275,000	6,193,000	6,459,000	6,432,000	6,145,000	6,806,000	6,305,000	5,992,000	5,944,000	5,950,000	6,014,000	5,867,000	5,477,000	5,444,000	5,301,000	5,073,000	5,160,000	5,068,000	4,419,000
benefit from deferred taxes												250,000				933,000						-13,408,000
net cash provided (used in) by financing activities												87,423,000
capital lease obligations												-18,194,000
consolidated statement of operations data:
net revenues
expenses
income before income tax (benefit) expense
income tax (benefit) expense
income from continuing operations
income from discontinued operations, net of taxes
less net income (income) attributable to noncontrolling interests
net income attributable to genesis healthcare, inc.
loss per common share:
weighted-average shares used for eps calculation
basic
diluted
net income per common share attributable to genesis healthcare, inc.:
other financial data:
net cash from investing activities, net of capital expenditures
balance sheet data:
cash and cash equivalents
working capital
property and equipment and leased facility assets
total assets
long-term debt, including current installments
capital lease obligations, including current installments
financing obligations, including current installments
stockholders' (deficit) equity
other non-cash charges and gains														2,378,000				-5,174,000	-42,922,000	12,000	9,387,000	-3,105,000
customer receivership														298,000
net change in restricted cash and equivalents														-2,701,000	-153,000	-1,643,000		20,596,000	-8,190,000	8,578,000	22,572,000	-6,828,000
purchases of inpatient assets, net of cash acquired																		-38,817,000	-68,704,000	-778,000
borrowings under revolving credit facility														127,000,000	175,000,000	176,000,000		195,000,000	243,000,000	224,000,000	275,000,000	223,000,000	220,000,000	146,500,000
repayments under revolving credit facility														-139,350,000	-170,300,000	-200,000,000		-152,000,000	-205,000,000	-254,000,000	-227,000,000	-201,000,000
net decrease in cash and cash equivalents																		7,162,000
cash and cash equivalents:
net taxes refunded														61,000	-68,000	-1,803,000
capital leases														0	0	-14,909,000		0			0	13,444,000
sale of investment in joint venture															0	242,000		0	0	1,010,000				26,358,000
net increase in cash and cash equivalents															12,952,000	385,000				-9,339,000	1,872,000
net taxes (refunded) paid																		4,207,000	196,000	-14,180,000
non-cash financing activities:
assumption of long-term debt																					0	111,000	110,166,000	326,610,000
sales of inpatient assets																				76,373,000
equity in net (income) loss of unconsolidated affiliates
long-lived asset impairment
transaction costs
issuance of stock
taxes paid																					1,910,000	5,314,000	7,752,000	5,917,000
sale of investment in joint ventures																						0
distributions to noncontrolling interests																						-2,517,000
cash and equivalents:
cash flows from operating activities:
total adjustments																								115,768,000
purchase of marketable securities
net increase in cash and equivalents																								8,160,000
supplemental disclosure of cash flow information:
change in fair value of contingent consideration																									-476,000	7,000	-121,000	14,000	-1,620,000	79,000
benefit from doubtful accounts																									3,763,000	3,737,000	3,720,000	2,905,000	5,638,000					1,740,000	1,787,000	1,775,000	2,035,000	1,037,000	1,938,000	2,457,000	2,191,000	2,232,000	2,599,000	2,595,000	2,707,000	1,648,000	4,881,000	1,803,000	3,185,000	3,377,000	2,097,000	1,428,000	2,642,000	959,000
non-cash stock-based compensation																									1,810,000	1,013,000	875,000	571,000	763,000	601,000	331,000	1,303,000	1,183,000	1,196,000	1,208,000	1,163,000	1,174,000	247,000	1,189,000	998,000	1,346,000	981,000	862,000	360,000	530,000	610,000	608,000	520,000	438,000	510,000	306,000	304,000	240,000	136,000
excess tax benefits from stock-based payment arrangements																																	0	0	0	242,000	54,000	0	-14,000	-295,000									0
gain on disposal of property and equipment
amortization of deferred financing costs																									742,000	723,000	903,000	900,000	768,000	779,000	685,000	638,000	640,000	530,000	818,000	825,000	851,000	826,000	825,000	826,000	825,000	923,000	723,000	1,421,000	1,422,000	1,421,000	1,074,000	794,000	793,000	794,000	795,000	686,000	636,000	583,000
deferred income taxes																									-7,000	-899,000	-444,000	918,000	1,755,000	-6,364,000	3,603,000	477,000	2,475,000	1,384,000	-1,162,000	793,000	59,000	-21,262,000	40,000	10,077,000	3,333,000	-4,923,000	1,052,000	484,000	1,642,000	5,214,000	-779,000	-111,000	177,000	380,000	-432,000	-784,000	3,377,000	-808,000
amortization of discount on debt																									134,000	134,000	141,000	141,000	186,000	235,000	237,000	238,000	318,000	156,000	288,000	144,000	168,000
debt retirement costs																																	0	168,000
impairment of long-lived assets																																					0
changes in operating assets and liabilities:
payments on notes receivable																									449,000	446,000	220,000	507,000	1,009,000	885,000	642,000	777,000	817,000	817,000	739,000	743,000	-798,000	2,226,000	927,000	959,000	1,446,000	1,507,000	950,000	943,000	2,052,000	1,828,000
other current and non-current assets																									-864,000	-764,000	4,280,000	-2,276,000	-3,558,000	-1,394,000	-31,000	-1,611,000	-2,037,000	1,257,000	284,000	-1,456,000	3,837,000	-4,587,000	9,212,000	-1,007,000	1,465,000	-8,349,000	-691,000	-597,000	3,983,000	-267,000	2,111,000	3,944,000	1,635,000	-437,000	1,304,000	-393,000
accounts payable and accrued liabilities																									-585,000	7,053,000	6,969,000	-5,671,000	3,752,000	1,696,000	-1,207,000	1,973,000	-7,750,000	2,952,000	-4,027,000	-1,303,000	3,526,000	-766,000	1,215,000	-3,482,000	4,762,000	-10,082,000	4,217,000	2,799,000	4,890,000	-5,553,000	3,960,000	-5,509,000	7,108,000	-2,939,000	-5,244,000	1,998,000	18,083,000	4,218,000
employee compensation and benefits																									-3,945,000	536,000	2,430,000	3,309,000	-4,154,000	-3,330,000	4,949,000	-5,277,000	4,060,000	-1,489,000	4,121,000	-5,609,000	4,781,000	329,000	1,604,000	-5,348,000	6,369,000	2,229,000	1,462,000	-879,000	-1,850,000	-730,000	289,000	694,000	-2,092,000	2,869,000	1,930,000	-2,352,000	3,420,000	3,961,000
insurance liability risks																									943,000	-863,000	-419,000	2,231,000	809,000	2,678,000	2,065,000	2,206,000	-1,544,000	-90,000	-1,060,000	1,057,000	450,000	-884,000	-1,635,000	538,000	310,000	-2,090,000	-2,753,000	143,000	-1,783,000	-879,000	-1,939,000	667,000	-2,342,000	202,000	-193,000	1,843,000	-2,578,000	40,000
other long-term liabilities																									495,000	162,000	298,000	-87,000	1,505,000	-1,858,000	1,311,000	-366,000	-203,000	-1,983,000	-1,094,000	132,000	1,279,000	-248,000	-838,000	847,000	-146,000	2,605,000	-1,672,000	52,000	356,000	493,000	288,000	53,000	650,000	1,879,000	476,000	392,000	-10,014,000	1,109,000
cash flows from investing activities
additions to property and equipment																									-3,738,000	-2,982,000	-2,711,000	-3,550,000	-3,459,000	-3,996,000	-3,580,000	-2,401,000	-7,009,000	-5,416,000	-3,622,000	-3,475,000	-5,182,000	-4,893,000	-3,656,000	-2,567,000	-4,575,000	-4,769,000	-8,694,000	-9,698,000	-11,973,000	-10,255,000	-8,499,000	-10,428,000	-15,156,000	-13,226,000	-12,311,000	-8,933,000	-9,000,000	-7,771,000
acquisitions																																	0	0
proceeds from sale of property and equipment																																	0	0				0	0	400,000
proceeds from sale of investments
proceeds from the sale of home health agency																									0
proceeds from the sale of land																									0
cash flows from financing activities
borrowings under line of credit																									74,000,000	67,500,000	78,500,000	78,500,000	109,499,000	89,083,000	76,000,000	89,000,000	72,500,000	72,000,000	149,000,000	13,500,000	0	21,500,000	11,000,000	55,500,000	19,500,000	52,500,000	54,500,000	48,000,000	78,000,000	-12,000,000	2,000,000	12,000,000	-5,000,000	6,000,000	2,000,000	10,000,000		48,000,000
repayments under line of credit																									-68,000,000	-70,335,000	-85,000,000	-78,057,000	-87,942,000	-126,583,000	-77,000,000	-84,000,000	-73,000,000	-82,000,000	-103,500,000	-13,500,000	0	-21,500,000	-25,000,000	-67,500,000	-38,500,000	-8,500,000	-118,500,000	-55,000,000
repayments of long-term debt																									-3,106,000	-1,759,000	-2,654,000	-2,087,000	-107,934,000	-57,934,000	-5,391,000	-3,730,000	-4,415,000	-3,514,000	-156,307,000	-1,187,000
cash paid for financing costs
proceeds from exercise of stock options																									316,000	0
taxes paid related to net share settlement of equity awards																									-1,574,000	-3,000	-9,000	-334,000	-81,000	34,000	-18,000	-204,000	-3,000	-2,000	-19,000	-210,000	40,000	-59,000
increase in cash and cash equivalents																									-6,907,000	2,576,000	3,755,000	28,000	1,582,000	576,000	-3,130,000	3,146,000	-1,196,000	-2,373,000			-425,000	1,427,000			992,000	3,043,000	-1,950,000	-1,421,000	293,000	-8,939,000	4,721,000	5,406,000
cash and cash equivalents at beginning of period																									0	0	0	4,177,000	0	0	0	2,003,000	0	0	0	16,017,000	0	0	0	4,192,000	0	0	0	3,528,000	0	0	0	2,047,000		0	0	5,012,000		0
cash and cash equivalents at end of period																									-6,907,000	2,576,000	3,755,000	4,205,000	1,582,000	576,000	-3,130,000	5,149,000	-1,196,000	-2,373,000	-4,309,000	9,881,000	-425,000	1,427,000	14,075,000	940,000	992,000	3,043,000	-1,950,000	2,107,000	293,000	-8,939,000	4,721,000	7,453,000		614,000	-279,000	3,992,000		-2,008,000
loss on disposal of assets																										68,000
debt modification/retirement costs																										21,000				432,000
impairment of long lived assets																										0
proceeds from maturity of investments																										0
payment of financing costs																										-186,000	-1,856,000	-181,000		-2,877,000
exercise of stock options																																					0	0	0	26,000
disposal of fixed assets																																										-1,708,000
acquisition of healthcare facilities and businesses, net of cash acquired																																					-10,372,000
proceeds from divestitures
provision for doubtful accounts																															3,114,000	2,983,000
loss on disposal of property and equipment
cash paid for purchase of previously leased facilities
disposal of property and equipment																																		24,000				0	3,000	290,000
additions to deferred financing costs																																		-257,000							0	214,000			0	0				0	0	-1,383,000		-319,000
acquisition of home health licenses																																						0	0	-350,000
decrease in cash and cash equivalents																																				-6,136,000				-3,252,000										614,000	-279,000	-1,020,000		-2,008,000
net income from continuing operations																																									10,841,000	-25,308,000	4,545,000	8,881,000	-161,316,000
net income from discontinued operations																																													0
tax benefit from reversal of accrual for uncertain tax positions																																													-624,000
write-off of deferred financing costs																																									0	0
proceeds from sale of land
repayments of long-term debt and capital leases																																					-18,396,000	-935,000	-939,000	-931,000	-3,304,000	-2,029,000	-251,128,000	-2,861,000	-2,861,000	-2,121,000	-2,842,000	-2,862,000
issuance of debt
cash flows from discontinued operations																																													0
proceeds from issuance long-term debt
amortization of discount and accretion on debt																																							152,000	140,000		148,000
acquisition of healthcare facilities and businesses																																										0
(gain) loss on disposal of asset
goodwill impairment charge
acquistion of healthcare facilities and businesses
proceeds from disposal of property and equipment
fees paid for early extinguishment of debt
change in the fair value of acquisition-related contingent consideration
change in the fair value of acquistion-related contingent consideration
loss on disposal of asset																																													0	1,000	0	60,000
amortization of discount on senior subordinated notes																																												27,000	27,000	27,000	26,000	27,000	27,000	26,000	27,000	27,000	27,000	31,000
change in other assets
premium on redemption of debt and write-off of deferred financing costs
change in fair value of interest rate hedge																																																					0	7,000
non-current income tax receivable
acquisition of healthcare facilities																																													-3,363,000	0			-308,000	-9,460,000			-1,210,000	-50,583,000
changes in other assets																																																-1,604,000		315,000	-14,000	-344,000	-689,000	-1,247,000
cash distributed related to the onex transaction																																																					0	0
proceeds from ipo, net of expenses
supplemental cash flow information
cash paid for:
interest expense, net of capitalized interest																																															3,932,000	11,691,000		11,556,000
income taxes																																															10,051,000	572,000	2,817,000	5,436,000
non-cash activities:
conversion of accounts receivable into notes receivable																																															4,950,000	5,307,000	0	0
change in notes receivable																																																336,000
operating activities
(gain) loss on sale of assets
investing activities
financing activities
repayments on long-term debt and capital leases																																																	-2,889,000	-1,767,000	-1,701,000	-2,884,000	-2,060,000	2,894,000
additions to deferred financing costs of new debt
proceeds from the issuance of new common stock
cash and cash equivalents at beginning of year
cash and cash equivalents at end of year
interest, net of capitalized interest
insurance premium financed																																																	-182,000
loss on sale of assets
write-off of deferred financing costs and premium on early redemption of debt																																																						0
principal payments on notes receivable
principal payments on (additions to) notes receivable																																																			669,000	488,000
reorganization expenses
cumulative effect of a change in accounting principle
gain on sale of assets
forgiveness of stockholder loan
other current assets																																																					2,684,000	-2,271,000
net cash paid for reorganization costs
borrowings (repayments) under line of credit
repayments on long-term debt through refinancing
redemption of preferred stock
purchase of treasury stock
proceeds from exercise of warrants and cash settlement of stock options
dividends paid
proceeds from capital contributions related to the onex transaction
proceeds from sale of interest rate hedge
purchase of interest rate hedge
supplemental disclosure of non-cash investing and financing activities:
reclassification of accounts receivable to notes receivable
(additions to) principal payments on notes receivable
premium paid for redemption of debt																																																						0
proceeds from initial public offering of common stock, net of expenses																																																						12,000
(additions) principal payments on notes receivable

Gen Digital Inc(NASDAQ:GEN)

Gen Digital Inc. is a multinational software company co-headquartered in Tempe, Arizona and Prague, Czech Republic. The company provides cybersecurity software and services. Gen is a Fortune 500 company and a member of the S&P 500 stock-market index.

Gen Digital Inc
(NASDAQ:GEN)